SCHEMBL5010068

SCHEMBL5010068

[CH]1CCCCCCCNNCCCC1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6998031 0.85
SCHEMBL7483937 0.83
SCHEMBL7413989 0.81
Piperidine SCHEMBL8488256 0.80 ALDH1A1 (0.60) ALDH1A1
SCHEMBL12988575 0.80
SCHEMBL5010069 0.80 ALDH1A1 (0.60) ALDH1A1
SCHEMBL4647537 0.78
SCHEMBL3284758 0.78
SCHEMBL1260534 0.78 ALDH1A1 (0.50) ALDH1A1
SCHEMBL815564 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951046-A2 METHODS TO ENHANCE CHEMOTHERAPY Genzyme Corporation (US) 2008-08-06 EP disclosed
WO-2007022523-A2 METHODS TO ENHANCE CHEMOTHERAPY GENZYME CORPORATION (US) 2007-02-22 WO disclosed